Publisher Correction: Pepinemab antibody blockade of SEMA4D in early Huntington's disease: a randomized, placebo-controlled, phase 2 trial

Affiliations

• ¹ New York University Langone Health and The Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, New York, NY, USA.
• ² Vaccinex, Inc., Research, Rochester, NY, USA.
• ³ IXICO, London, UK.
• ⁴ WCG Statistics Collaborative, Inc., Washington, DC, USA.
• ⁵ University of Rochester Medical Center, Rochester, NY, USA.
• ⁶ Siemers Integration LLC, Zionsville, IN, USA.
• ⁷ Vaccinex, Inc., Research, Rochester, NY, USA. mzauderer@vaccinex.com.